在自身免疫性肝炎的维持治疗中,贝切特病的发展
George Thieroff1, Samantha Jane Bartholow2, Adam Kilian3
1Rheumatology, Saint Louis University, Saint Louis, Missouri, USA george.thieroff@gmail.com.
BMJ case reports
|December 18, 2024
概括
本案例研究突出了一个罕见的贝切特病案例,在经过十年的其他自身免疫疾病后表现出来,提出了诊断挑战. 成功的治疗涉及治疗组合,包括infliximab和azathioprine.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 贝切特病是一种罕见的多系统血管炎,具有多样化的临床表现.
- 在贝塞特病中,肝脏的参与是不常见的,特别是在没有血管并发症的情况下.
研究的目的:
- 描述一个独特的贝塞特病病例,在经过十年的其他自身免疫诊断后发展.
- 为了说明患有重叠自身免疫性疾病的患者的诊断复杂性.
- 在此背景下,强调成功治疗贝塞特病的治疗策略.
主要方法:
- 病例报告详细介绍患者的临床病史,诊断工作和治疗过程.
- 对贝塞特病和其他自身免疫性疾病的诊断标准的审查.
- 对各种免疫抑制剂和生物药物的治疗反应的监测.
主要成果:
- 一名患有哈西莫托甲状腺炎和自身免疫性肝炎的患者出现了广泛的口腔,伪皮炎,红斑结节状病变,皮肤以及积极的皮肤炎现象.
- 覆盖自身免疫结合组织疾病的初始诊断被修订为贝切特病.
- 通过联合使用因弗利西马布,阿扎西奥普林,科尔奇辛和阿普雷米拉斯特,成功实现了管理.
结论:
- 这一案例强调了贝塞特病的变异性和有时延迟的表现.
- 诊断警对于在有其他自身免疫性疾病病史的患者中识别贝塞特病至关重要.
- 多药疗法可以有效地管理复杂的贝切特病表现.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
115
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
115
Chronic Bowel Disorders: Introduction
386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
Autoimmune Disorders
385
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
385
Inflammatory Bowel Disease IV: Pharmacological Management
111
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
111
Gastritis-II: Pathophysiology
242
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
242


